A shockwave from a star that shouldn't be producing one. A brain that might actually be two organs in disguise. Worms beating death with the help of magnetic bacteria. And NASA spotting a fresh scar on the Moon. Today's science is moving fast - here's everything you need to know.

A dead star is generating a shockwave that, according to our current understanding of physics, should not exist. Scientists studying the phenomenon were so stunned by the finding that their immediate response was to declare they had found something genuinely unprecedented - a phrase researchers rarely use lightly. Dead stars, by definition, are no longer undergoing the processes we associate with powerful energy output, making this observation deeply puzzling.

The discovery challenges models that describe what happens after a star dies, and forces physicists to reconsider what these remnant objects are still capable of. Shockwaves of this nature require enormous energy drivers - and identifying where that energy is coming from in a dead star is now the central mystery researchers are racing to solve.

This finding matters because it exposes a genuine gap in our models of stellar evolution. If dead stars can still drive shockwaves, we may be vastly underestimating the long-term energy output of stellar remnants throughout the universe - with implications for how galaxies evolve over billions of years.

Stanford researchers have put forward a striking new theory: the human brain may not be a single unified organ at all, but rather two separate organs that fused together. The idea reframes decades of neuroscience and suggests that the architecture of the brain is far more complex - and far stranger - than the field has assumed. This is the kind of structural insight that, if confirmed, would ripple through medicine, psychology, and our most basic understanding of human cognition.

The implications stretch well beyond academic curiosity. If the brain is functionally two fused structures, it could explain asymmetries in neurological conditions, why certain brain injuries affect people so differently, and why treatments that work on one hemisphere sometimes fail on the other. Stanford's finding invites a fundamental rethink of how we study and treat the brain.

Neuroscience has long treated the brain as one integrated system. If Stanford's hypothesis holds up to scrutiny, it could transform neurological research and open entirely new avenues for treating conditions from depression to epilepsy - by understanding which "organ" is actually affected.

In one of the more unexpected longevity findings in recent memory, scientists introduced magnetic bacteria into worms and watched their lifespans extend by 43%. That's not a small bump - that's a dramatic extension that has researchers asking serious questions about what these bacteria are doing at the cellular level to slow the aging process. The worm model is a well-established workhorse for aging research, meaning findings here often point toward broader biological truths.

The magnetic bacteria appear to trigger survival mechanisms inside the worms that wouldn't otherwise activate. Untangling exactly which pathways are involved - and whether anything analogous exists in more complex organisms - is the immediate next frontier for this research team. The word "magnetic" here isn't a metaphor: these are literal bacteria with magnetic properties, making the mechanism even more intriguing.

A 43% lifespan extension is extraordinary in any model organism. While worms are not humans, the cellular pathways involved in aging are often conserved across species. This research could eventually point toward entirely new strategies for extending healthy human lifespan - through biology we've barely begun to explore.

NASA has identified a massive new crater on the Moon caused by what scientists are describing as a once-in-a-century impact event. The discovery is a vivid reminder that the Solar System is not a static, finished place - rocks are still colliding, surfaces are still being reshaped, and the Moon's face is being rewritten in real time, even as we watch from Earth.

For planetary scientists, fresh craters are treasure troves of information. A newly formed crater exposes subsurface material that would otherwise be inaccessible, offering a window into the Moon's interior composition. Studying the ejecta and crater morphology also helps scientists calibrate impact models - knowledge that's directly applicable to understanding impact hazards in our own cosmic neighborhood.

Once-in-a-century lunar impacts aren't just spectacular - they're scientifically invaluable. This fresh crater gives researchers a rare, unweathered look at what lies beneath the Moon's surface, and sharpens our models of how often large impactors still threaten bodies in the inner Solar System - including Earth.

Since the James Webb Space Telescope began returning data, one puzzle has nagged at astronomers: strange, compact red objects appearing in deep field images that didn't fit neatly into existing categories. These "little red dots" were too bright, too compact, and too red to be easily explained. Today, scientists report they may have cracked what these objects actually are - a finding that would resolve one of Webb's most persistent early mysteries.

The resolution of this mystery matters beyond satisfying curiosity. The little red dots appear in observations of the very early universe, meaning whatever they are, they're telling us something about how structure formed in the cosmos shortly after the Big Bang. Getting the identification right is essential to building accurate models of early galaxy and black hole formation.

Pancreatic cancer has one of the lowest survival rates of any cancer - in large part because it's so difficult to treat. That's what makes today's research so striking: a new mRNA-based immunotherapy caused pancreatic cancer to disappear entirely in mice. The same mRNA technology that powered COVID-19 vaccines is now being aimed at one of medicine's most stubborn targets, and the early results in animal models are drawing serious attention.

The approach harnesses the immune system rather than trying to poison cancer cells directly - a strategy that has proven more durable in other cancer types. By programming immune cells to recognize and attack pancreatic tumor cells specifically, researchers achieved complete tumor elimination in their mouse models. The leap from mice to humans is never guaranteed, but results this clean in preclinical models are exactly the kind of signal that accelerates a therapy toward clinical trials.

Pancreatic cancer kills the vast majority of patients within five years of diagnosis. If mRNA immunotherapy can replicate even a fraction of these mouse results in human trials, it would represent one of the most meaningful advances in oncology in decades - and a vindication of the broader mRNA platform beyond infectious disease.

From the Moon's surface to the interior of a worm cell, from the ruins of a dead star to the hidden structure of your own brain - today's science is a reminder that we are still, in the most fundamental sense, explorers. The most important discoveries are still ahead of us. We'll be here when they arrive.